- 专利标题： RAPID-ACTING INSULIN COMPOSITIONS
-
申请号： EP16771021.9申请日： 2016-08-19
-
公开(公告)号： EP3340966A1公开(公告)日： 2018-07-04
- 发明人: AKERS, Michael Patrick , CHRISTE, Michael Edward , HARDY, Thomas Andrew , MAJUMDAR, Ranajoy , NGUYEN, Chi A. , PAAVOLA, Chad D. , SARIN, Virender Kumar , SCHULTE, Nanette Elizabeth
- 申请人： Eli Lilly and Company
- 申请人地址： Lilly Corporate Center Indianapolis, IN 46285 US
- 专利权人： Eli Lilly and Company
- 当前专利权人： Eli Lilly and Company
- 当前专利权人地址： Lilly Corporate Center Indianapolis, IN 46285 US
- 代理机构： Kent, Lindsey Ruth
- 优先权： US201562210469P 20150827
- 国际公布： WO2017034956 20170302
- 主分类号： A61K9/00
- IPC分类号： A61K9/00 ; A61K38/28 ; A61K47/02 ; A61K47/12 ; A61K31/557
摘要：
The invention is a pharmaceutical composition of human insulin or insulin analog that includes citrate, treprostinil and stabilizing agents, that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products and that is stable for commercial use.
公开/授权文献
- EP3340966B1 RAPID-ACTING INSULIN COMPOSITIONS 公开/授权日：2022-10-12
信息查询
